Who Paid My Doc Search
Menu
Product Program year 2020 Source: CMS Open Payments

Pelacarsen

Drug

Open in the dashboard

General payments

$72,407

25 payments

Research payments

$105,386

11 payments

Through program year 2020, $72,407 in general payments and $105,386 in research payments were reported against Pelacarsen.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $72,407 25
2020 Research $105,386 11

Breakdown

Who paid General payments · program year 2020
  1. Novartis Pharmaceuticals Corporation $72,407 25 payments
Top recipients General payments · program year 2020
  1. Howard Weintraub Cardiovascular Disease · New York, NY $9,062 13% · 2 payments
  2. Seth Baum Cardiovascular Disease · Boca Raton, FL $8,910 12% · 2 payments
  3. Michael Shapiro Cardiovascular Disease · Winston-Salem, NC $7,200 10% · 2 payments
  4. Robert Rosenson Cardiovascular Disease · New York, NY $7,200 10% · 2 payments
  5. Matthew Budoff Cardiovascular Disease · Torrance, CA $6,086 8% · 2 payments

The top 5 of 13 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Cardiovascular Disease Internal Medicine $49,701 69% · 7 practitioners
  2. Internal Medicine $16,863 23% · 4 practitioners
  3. Endocrinology, Diabetes & Metabolism Internal Medicine $3,935 5% · 1 practitioner
  4. Clinical Pharmacology $1,908 3% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. New York $16,262 22% · 2 recipients
  2. Oregon $11,135 15% · 2 recipients
  3. Florida $8,910 12% · 1 recipient
  4. California $6,086 8% · 1 recipient
  5. Michigan $5,963 8% · 1 recipient

The top 5 of 11 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

Records

25 general · 11 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record